Looks like sage 217 has finally been released to public 2023

Therapeutic Efforts
#1
1 Like
#2

The date for that article says 2023. Does that mean it’s available?

#3

This could be had for awhile now from third party sources.
That being said. I was part of the trials - and it did nothing for any of my sides…

1 Like
#4

@tjanok - So you have been a participant of the clinical SAGE studies? Many sufferers set big hopes in SAGE therapies. Did you contat the FDA or did you contact SAGE therapeutic directly to be a study participant.
I think this is a very interesting topic for many community members. What about your pfs, did they accept this?

It’s a big project of the pfs foundation…

https://www.businesswire.com/news/home/20220429005707/en/Sage-Therapeutics-and-Biogen-Initiate-Rolling-Submission-of-New-Drug-Application-NDA-to-U.S.-Food-and-Drug-Administration-for-Zuranolone-for-the-Potential-Treatment-of-Major-Depressive-Disorder-MDD

And a big project of SAGE therapeutics.

1 Like
#5

My reading comprehension is 0. Could this drug upregulate/deregulate Gaba-a receptors? Or they act on Gaba but in a safe way?

On the other hand I see they developing another drug for cognition/memory (sage 718)